Long-Term Experience With 5-Alpha-Reductase Inhibitors

    January 2003 in “ PubMed ”
    Jr E. Darracott Vaughan
    Studysummary Finasteride reduces prostate size and symptoms with few side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 9

    1. The Clinical Applications of Five-Alpha Reductase Inhibitors Canadian Journal of Urology · 2021
    2. The Cardiovascular Safety of Dutasteride ˜The œJournal of urology/˜The œjournal of urology · 2016
    3. Current Pharmacological Treatment for Male LUTS Due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015
    4. Finasteride: Its Impact on Sexual Function and Prostate Cancer Journal of Cutaneous and Aesthetic Surgery · 2009
    5. Finasteride for Prostatic Disease: An Updated and Comprehensive Review Expert opinion on drug metabolism & toxicology · 2008
    6. 5α-Reductase: History And Clinical Importance PubMed Central · 2004
    7. A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia Drug safety · 1998
    8. Current Treatment of Benign Prostatic Hyperplasia Biomedicine & pharmacotherapy · 1995
    9. Finasteride Drugs · 1993